TY  - JOUR
AU  - Straburzynska-Migaj, Ewa
AU  - Senni, M
AU  - Wachter, R
AU  - Fonseca, C
AU  - Witte, K K
AU  - Mueller, C
AU  - Lonn, E
AU  - Butylin, D
AU  - Noe, A
AU  - Schwende, H
AU  - Lawrence, D
AU  - Suryawanshi, B
AU  - Pascual-Figal, Domingo A
PY  - 2024
DO  - 10.1016/j.cardfail.2023.08.021
UR  - http://hdl.handle.net/20.500.12105/19248
AB  - BACKGROUNDTreatment of patients with heart failure with reduced ejection fraction (HFrEF) and renal dysfunction (RD) is challenging owing to the risk of further deterioration in renal function, especially after acute decompensated HF (ADHF).METHODS...
LA  - eng
PB  - Elsevier
KW  - Heart Failure
KW  - Kidney Diseases
KW  - Ventricular Dysfunction, Left
KW  - Humans
KW  - Aminobutyrates
KW  - Angiotensin Receptor Antagonists
KW  - Biomarkers
KW  - Biphenyl Compounds
KW  - Drug Combinations
KW  - Stroke Volume
KW  - Tetrazoles
KW  - Treatment Outcome
KW  - Valsartan
TI  - Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study.
TY  - journal article
ER  -